Texas Biomedical Research Institute
San Antonio, Texas, United States
Purpose
to identify the regions of the Schistosoma mansoni genome that underlie resistance to the drug praziquantel and thereby provide a starting point for identifying and validating genetic markers for monitoring drug resistance in schistosomiasi
Division
Global Health
Date
August 2017
Region Served
AFRICA
Committed amount
$356,656
Grant topic
Neglected Tropical Diseases
Duration (months)
59
Grantee location
San Antonio, Texas, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.